Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-07 21:56:47 - browse：5

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about 2,000 patients are taking the medicine nationwide, the company said Tuesday.

Biogen’s chief executive, Christopher A. Viehbacher, said as the firm released fourth-quarter earnings that he had expected the slow uptake and sees considerable demand for the medication. He told reporters that 3,800 patients with early-stage Alzheimer’s have signed up on multiple registries to receive the drug, called Leqembi, as of last month.

Before patients can get the drug, which costs $26,500-a-year, they must undergo a brain scan or a spinal tap to confirm that they have build-up of deposits of a sticky toxic protein called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Nonprofit, backed by Microsoft, to certify AI tools in health care

hotspot

WSS

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Head of FDA's diagnostics center, who led through Covid, retires

Medicare bonuses could stop drug shortages under Senate plan

Life science postdocs should get big pay hike, NIH panel says

Medicare drug price lawsuits could be good politics for Biden

Flu vaccine reformulation won't be easy, manufacturers warn

hotspot

Wikipedia

focus

Duchenne breakthrough therapy leaves behind pioneering families

Head of FDA's diagnostics center, who led through Covid, retires

What does generative AI mean for health care? We asked experts

The inclusion problem at the heart of rehabilitation research

23andMe had bad news about my health. I wish a person had delivered it

Cardiologists urge adding sexual orientation, gender identity to health records

Supreme Court strikes down use of affirmative action

CVS is on a mission to consolidate health care. Will it work?

Medicare proposal to cover medical devices draws a mixed reaction

Does Paxlovid work in people vaccinated against Covid

entertainment

At JPM 2024, hospital systems pitch financial strength to investors

Does Paxlovid work in people vaccinated against Covid

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Male doctors called my cancer incurable. A female doctor showed it wasn't

Maisha Meds is a PBM, but don't call it that

American taxpayers paid $1.8 trillion in health care costs in 2022

entertainment

hotspot

hotspot

explore